Andrew Lam
UNSW Sydney(AU)Ingham Institute(AU)
Publications by Year
Research Areas
Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, RNA Research and Splicing, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors(2012)620 cited
- → Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types(2016)113 cited
- → Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells(2021)62 cited
- → Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo(2009)62 cited
- → Sequence and structural organization of the human gene encoding ciliary neurotrophic factor(1991)61 cited
- → Application of in vitro–in vivo correlations (IVIVC) in setting formulation release specifications(2000)47 cited
- → Abstract 2003: Antibody against TIGIT (T cell immunoreceptor with Ig and ITIM domains) induces anti-tumor immune response and generates long-term immune memory(2017)9 cited
- → Construction of a broad-host-range kanamycin-resistant plasmid vector(1983)6 cited
- → Abstract 5627: Anti-TIGIT biomarker study: Inhibition of TIGIT induces loss of Tregs from tumors and requires effector function for tumor growth inhibition(2018)5 cited
- → Abstract 2612: Anti-Tigit induces T cell mediated anti-tumor immune response and combines with immune checkpoint inhibitors to enhance strong and long term anti-tumor immunity(2017)5 cited